|
시장보고서
상품코드
1539395
전임상 이미징 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2031년)Preclinical Imaging Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031 |
||||||
Persistence Market Research는 이번에 세계의 전임상 이미징 시장에 관한 종합 보고서를 발표했습니다. 본 리포트에서는 주요 촉진요인, 동향, 기회 및 과제 등 필수적인 시장 역학을 상세하게 평가하고, 시장 구조에 관한 상세한 인사이트를 제공하고 있습니다.
주요 인사이트
- 전임상 이미징 시장 규모(2024년) : 43억 달러
- 예측 시장 금액(2031년) : 59억 6,000만 달러
- 세계 시장 성장률(CAGR 2024-2031년) : 4.55%
전임상 이미징 시장 - 리포트 범위 :
임상 전 이미징은 신약 및 치료법 개발에 있으며, 매우 중요하며, 연구자들이 초기 단계에서 개입의 효과를 시각화하고 이해할 수 있도록 도와줍니다. 전임상 이미징 시장에는 MRI, PET, CT, 광학 이미징 시스템 등 다양한 이미징 기술이 포함됩니다. 이러한 기술은 학술기관, 제약사, CRO 등 다양한 연구 환경에서 채택되어 의약품 개발, 질병 연구, 치료 효과 연구를 지원하고 있습니다.
연구용 첨단 이미징 기술에 대한 수요 증가, 신약개발에 대한 투자 증가, 이미징 해상도와 정확도를 높이는 기술 발전이 시장 성장의 원동력이 되고 있습니다. 또한 만성질환의 확산과 맞춤형 의료에 대한 요구가 증가함에 따라 시장 확대가 더욱 가속화되고 있습니다.
시장 성장의 촉진요인:
세계 전임상 이미징 시장을 주도하는 몇 가지 주요 요인은 다음과 같습니다. 고해상도 MRI 및 PET/CT 시스템의 통합과 같은 이미징 기술의 급속한 발전으로 연구 역량이 크게 향상되었습니다. 제약 및 생명공학 기업의 R&D 투자 증가는 의약품 개발 프로세스를 가속화하기 위한 고급 이미징 솔루션에 대한 수요를 촉진하고 있습니다. 또한 만성질환 증가와 맞춤형 의료의 필요성이 정확한 질병 모델링 및 치료 평가를 위한 첨단 영상 기술의 채택을 촉진하고 있습니다.
분자 이미징 및 멀티모달 이미징 시스템의 개척과 같은 기술 혁신도 시장 성장에 기여하고 있습니다. 이러한 혁신은 전임상 연구의 정확도를 높이고, 생물학적 과정을 보다 상세하게 분석할 수 있게 하여 새로운 치료법과 치료법의 발전을 지원하고 있습니다.
시장 성장 억제요인 :
임상 전 이미징 시장은 유망한 성장 전망에도 불구하고 몇 가지 도전 과제에 직면해 있습니다. 특히 소규모 연구기관이나 개발도상국의 R&D 기관에서는 첨단 이미징 시스템과 관련된 높은 비용이 보급을 제한할 수 있습니다. 또한 이미징 기술의 복잡성과 전문적 훈련의 필요성은 효과적인 활용에 장벽이 될 수 있습니다. 규제적 제약과 새로운 이미징 기술의 승인 절차에 시간이 오래 걸리는 것도 시장 역학에 영향을 미칠 수 있습니다.
이러한 문제를 해결하기 위해서는 비용 절감, 사용자 교육 강화, 규제 경로 간소화 등 첨단 이미징 솔루션에 대한 폭넓은 접근을 촉진하기 위한 지속적인 노력이 필요합니다.
시장 기회 :
임상 전 이미징 시장은 기술 발전과 연구 활동의 활성화로 인해 큰 성장 기회를 맞이하고 있습니다. 휴대가 간편하고 비용 효율적인 이미징 솔루션의 개발과 데이터 분석을 위한 AI 및 머신러닝의 통합은 시장 확대의 새로운 길을 열어줄 것입니다. 또한 연구기관, 기술 개발자, 제약사 간의 협업은 기술 혁신을 촉진하고 첨단 이미징 기술의 채택을 가속화할 것으로 예상됩니다.
개인맞춤형 의료와 표적치료에 대한 관심이 높아짐에 따라 특정 연구 수요에 맞는 특수 영상처리 시스템을 개발할 수 있는 기회도 확대되고 있습니다. 전략적 파트너십, 첨단 기술에 대한 투자, 신흥 시장 진출은 이러한 기회를 활용하고 시장 성장을 지속하기 위해 매우 중요합니다.
이 보고서에서 다룬 주요 질문
- 전 세계 전임상 이미징 시장의 성장을 가속하는 주요 요인은?
- 전임상 연구에서 어떤 이미징 기술과 용도가 선호되고 있는가?
- 기술의 발전은 전임상 이미징 시장 경쟁 구도를 어떻게 변화시키고 있는가?
- 전임상 이미징 시장에 기여하고 있는 주요 기업은 어디이며, 시장 관련성을 유지하기 위해 어떤 전략을 채택하고 있는가?
- 세계 전임상 이미징 시장의 새로운 동향과 미래 전망은?
목차
제1장 개요
제2장 시장 개요
- 시장의 범위와 정의
- 시장 역학
- 촉진요인
- 억제요인
- 기회
- 과제
- 주요 동향
- 전임상 이미징 시장 : 밸류체인
- 주요 기업 리스트
- 주요 판매 대리점 리스트
- 예측 요인 - 관련성과 영향
- COVID-19의 영향 평가
- PESTLE 분석
- Porter’s Five Forces 분석
제3장 주요 규제/기준
제4장 가격 동향 분석, 2019-2031년
- 가격에 영향을 미치는 주요 요인
- 가격 : 소스별
제5장 세계의 전임상 이미징 시장 전망 : 실적(2019-2023년)과 예측(2024-2031년)
- 시장 규모(10억 달러) 분석과 예측
- 과거 시장 규모 분석, 2019-2023년
- 현재 시장 규모 예측, 2024-2031년
- 세계의 전임상 이미징 시장 전망 : 제품 유형
- 과거 시장 규모(10억 달러) 분석, 제품 유형별, 2019-2023년
- 현재 시장 규모(10억 달러) 예측, 제품 유형별, 2024-2031년
- 시장의 매력 분석 : 제품 유형
- 세계의 전임상 이미징 시장 전망 : 용도
- 과거 시장 규모(10억 달러) 분석, 용도별, 2019-2023년
- 현재 시장 규모(10억 달러) 예측, 용도별, 2024-2031년
- 시장의 매력 분석 : 용도
- 세계의 전임상 이미징 시장 전망 : 최종사용자
- 과거 시장 규모(10억 달러) 분석, 최종사용자별, 2019-2023년
- 현재 시장 규모(10억 달러) 예측, 최종사용자별, 2024-2031년
- 시장의 매력 분석 : 최종사용자
제6장 세계의 전임상 이미징 시장 전망 : 지역
- 과거 시장 규모(10억 달러) 분석, 지역별, 2019-2023년
- 현재 시장 규모(10억 달러) 예측, 지역별, 2024-2031년
- 북미
- 유럽
- 동아시아
- 남아시아·오세아니아
- 라틴아메리카
- 중동 및 아프리카
- 시장의 매력 분석 : 지역
제7장 북미의 전임상 이미징 시장 전망 : 실적(2019-2023년)과 예측(2024-2031년)
제8장 유럽의 전임상 이미징 시장 전망 : 실적(2019-2023년)과 예측(2024-2031년)
제9장 동아시아의 전임상 이미징 시장 전망 : 실적(2019-2023년)과 예측(2024-2031년)
제10장 남아시아·오세아니아의 전임상 이미징 시장 전망 : 실적(2019-2023년)과 예측(2024-2031년)
제11장 라틴아메리카의 전임상 이미징 시장 전망 : 실적(2019-2023년)과 예측(2024-2031년)
제12장 중동 및 아프리카의 전임상 이미징 전망 : 실적(2019-2023년)과 예측(2024-2031년)
제13장 경쟁 구도
- 시장 점유율 분석, 2024년
- 시장 구조
- 경쟁 격화 맵 : 시장별
- 경쟁 대시보드
- 계층 구조 분석
- 지역 프레즌스 분석
- 기업 개요(상세 - 개요, 재무, 전략, 최근 동향)
- Bruker Corporation
- Siemens AG
- General Electric(GE)
- TriFoil Imaging
- PerkinElmer, Inc.
- VisualSonics Inc.(Fujifilm)
- Mediso Ltd.
- Agilent Technologies
- MILabs BV
- MR Solutions
- Molecubes
제14장 부록
- 조사 방법
- 조사의 전제조건
- 두자어와 약어
Persistence Market Research has recently released a comprehensive report on the global preclinical imaging market. This report provides an in-depth evaluation of essential market dynamics, including key drivers, trends, opportunities, and challenges, delivering detailed insights into the market structure.
Key Insights:
- Preclinical Imaging Market Size (2024E): US$4.3 Bn
- Projected Market Value (2031F): US$5.96 Bn
- Global Market Growth Rate (CAGR 2024 to 2031): 4.55%
Preclinical Imaging Market - Report Scope:
Preclinical imaging is pivotal in the development of new drugs and therapies, allowing researchers to visualize and understand the effects of interventions at an early stage. The preclinical imaging market encompasses a range of imaging technologies, including MRI, PET, CT, and optical imaging systems. These technologies are employed in various research settings, including academic institutions, pharmaceutical companies, and contract research organizations (CROs), to support drug development, disease research, and therapeutic efficacy studies.
Market growth is driven by the increasing demand for advanced imaging techniques in research, rising investments in drug discovery, and technological advancements that enhance imaging resolution and accuracy. Additionally, the growing prevalence of chronic diseases and the need for personalized medicine further propel market expansion.
Market Growth Drivers:
Several key factors are driving the global preclinical imaging market. The rapid evolution of imaging technologies, such as the integration of high-resolution MRI and PET/CT systems, is significantly enhancing research capabilities. Increased investment in R&D by pharmaceutical and biotechnology companies is fueling demand for sophisticated imaging solutions to accelerate drug development processes. Moreover, the rise in chronic diseases and the need for personalized medicine are driving the adoption of advanced imaging technologies for precise disease modeling and therapeutic assessments.
Technological innovations, including advancements in molecular imaging and the development of multimodal imaging systems, are also contributing to market growth. These innovations improve the accuracy of preclinical studies and enable more detailed analysis of biological processes, supporting the advancement of new treatments and therapies.
Market Restraints:
Despite promising growth prospects, the preclinical imaging market faces several challenges. The high cost associated with advanced imaging systems can limit their adoption, particularly among smaller research institutions and organizations in developing regions. Additionally, the complexity of imaging technologies and the need for specialized training can pose barriers to effective utilization. Regulatory constraints and the lengthy approval processes for new imaging technologies may also impact market dynamics.
Addressing these challenges requires ongoing efforts to reduce costs, enhance user training, and streamline regulatory pathways to facilitate broader access to advanced imaging solutions.
Market Opportunities:
The preclinical imaging market presents significant growth opportunities driven by technological advancements and increasing research activities. The development of portable and cost-effective imaging solutions, as well as the integration of AI and machine learning for data analysis, offers new avenues for market expansion. Furthermore, collaborations between research institutions, technology developers, and pharmaceutical companies are expected to drive innovation and accelerate the adoption of advanced imaging technologies.
The growing focus on personalized medicine and targeted therapies also opens up opportunities for the development of specialized imaging systems tailored to specific research needs. Strategic partnerships, investment in cutting-edge technologies, and expansion into emerging markets will be crucial for capitalizing on these opportunities and sustaining market growth.
Key Questions Answered in the Report:
- What are the primary factors driving the growth of the preclinical imaging market globally?
- Which imaging technologies and applications are gaining traction in preclinical research?
- How are technological advancements reshaping the competitive landscape of the preclinical imaging market?
- Who are the key players contributing to the preclinical imaging market, and what strategies are they employing to maintain market relevance?
- What are the emerging trends and future prospects in the global preclinical imaging market?
Competitive Intelligence and Business Strategy:
Leading players in the global preclinical imaging market, including Siemens Healthineers, GE Healthcare, and Bruker Corporation, are focusing on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced imaging systems, such as high-resolution MRI and PET/CT scanners, and integrate cutting-edge technologies like AI for enhanced imaging capabilities. Collaborations with research institutions, pharmaceutical companies, and CROs facilitate market access and promote technology adoption. Emphasis on clinical research, evidence-based practices, and user training is essential for driving market growth and advancing preclinical imaging capabilities.
Key Companies Profiled:
- Bruker Corporation
- Siemens A.G.
- General Electric (GE)
- TriFoil Imaging
- PerkinElmer, Inc.
- VisualSonics Inc. (Fujifilm)
- Mediso Ltd.
- Agilent Technologies
- MILabs B.V.
- MR Solutions
- Molecubes
Preclinical Imaging Market Research Segmentation
By Product Type
- Imaging Systems
- Reagents
By Application
- Research and Development
- Drug Discovery
By End User
- Pharmaceutical & Biotechnology Companies
- Academic and research centres
- Imaging Centres
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- The Middle East and Africa
Table of Contents
1. Executive Summary
- 1.1. Global Preclinical Imaging Market Snapshot, 2024-2031
- 1.2. Market Opportunity Assessment, 2024-2031, US$ Bn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Industry Developments and Key Market Events
- 1.6. PMR Analysis and Recommendations
2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
- 2.3. Preclinical Imaging Market: Value Chain
- 2.3.1. List of key players
- 2.3.2. List of key distributors
- 2.4. Forecast Factors - Relevance and Impact
- 2.5. Covid-19 Impact Assessment
- 2.6. PESTLE Analysis
- 2.7. Porter Five Force's Analysis
3. Key Regulations/ Standards
4. Price Trend Analysis, 2019-2031
- 4.1. Key Factors Impacting Prices
- 4.2. Prices by Source
5. Global Preclinical Imaging Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
- 5.1. Market Size (US$ Bn) Analysis and Forecast
- 5.1.1. Historical Market Size Analysis, 2019-2023
- 5.1.2. Current Market Size Forecast, 2024-2031
- 5.2. Global Preclinical Imaging Market Outlook: Product Type
- 5.2.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
- 5.2.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
- 5.2.2.1. Imaging Systems
- 5.2.2.1.1. Optical Imaging Systems
- 5.2.2.1.2. Nuclear Imaging Systems
- 5.2.2.1.3. Micro MRI Systems
- 5.2.2.1.4. Micro Ultrasound Systems
- 5.2.2.1.5. Micro CT Systems
- 5.2.2.1.6. Photoacoustic Imaging Systems
- 5.2.2.1.7. Magnetic Particle Imaging Systems
- 5.2.2.2. Reagents
- 5.2.2.2.1. Preclinical Optical Imaging Reagents
- 5.2.2.2.2. Preclinical Nuclear Imaging Reagents
- 5.2.2.2.3. Preclinical MRI Contrast Agents
- 5.2.2.2.4. Preclinical CT Contrast Agents
- 5.2.2.2.5. Software
- 5.2.2.1. Imaging Systems
- 5.2.3. Market Attractiveness Analysis: Product Type
- 5.3. Global Preclinical Imaging Market Outlook: Application
- 5.3.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
- 5.3.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
- 5.3.2.1. Research and Development
- 5.3.2.2. Drug Discovery
- 5.3.3. Market Attractiveness Analysis: Application
- 5.4. Global Preclinical Imaging Market Outlook: End-user
- 5.4.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
- 5.4.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
- 5.4.2.1. Pharmaceutical & Biotechnology Companies
- 5.4.2.2. Academic and research centres
- 5.4.2.3. Imaging Centres
- 5.4.2.4. Other End-users
- 5.4.3. Market Attractiveness Analysis: End-user
6. Global Preclinical Imaging Market Outlook: Region
- 6.1. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
- 6.2. Current Market Size (US$ Bn) Forecast By Region, 2024-2031
- 6.2.1. North America
- 6.2.2. Europe
- 6.2.3. East Asia
- 6.2.4. South Asia and Oceania
- 6.2.5. Latin America
- 6.2.6. Middle East & Africa
- 6.3. Market Attractiveness Analysis: Region
7. North America Preclinical Imaging Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
- 7.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
- 7.1.1. By Country
- 7.1.2. By Product Type
- 7.1.3. By Application
- 7.1.4. By End-user
- 7.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
- 7.2.1. U.S.
- 7.2.2. Canada
- 7.3. North America Preclinical Imaging Market Outlook: Product Type
- 7.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
- 7.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
- 7.3.2.1. Imaging Systems
- 7.3.2.1.1. Optical Imaging Systems
- 7.3.2.1.2. Nuclear Imaging Systems
- 7.3.2.1.3. Micro MRI Systems
- 7.3.2.1.4. Micro Ultrasound Systems
- 7.3.2.1.5. Micro CT Systems
- 7.3.2.1.6. Photoacoustic Imaging Systems
- 7.3.2.1.7. Magnetic Particle Imaging Systems
- 7.3.2.2. Reagents
- 7.3.2.2.1. Preclinical Optical Imaging Reagents
- 7.3.2.2.2. Preclinical Nuclear Imaging Reagents
- 7.3.2.2.3. Preclinical MRI Contrast Agents
- 7.3.2.2.4. Preclinical CT Contrast Agents
- 7.3.2.2.5. Software
- 7.3.2.1. Imaging Systems
- 7.4. North America Preclinical Imaging Market Outlook: Application
- 7.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
- 7.4.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
- 7.4.2.1. Research and Development
- 7.4.2.2. Drug Discovery
- 7.5. North America Preclinical Imaging Market Outlook: End-user
- 7.5.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
- 7.5.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
- 7.5.2.1. Pharmaceutical & Biotechnology Companies
- 7.5.2.2. Academic and research centres
- 7.5.2.3. Imaging Centres
- 7.5.2.4. Other End-users
- 7.6. Market Attractiveness Analysis
8. Europe Preclinical Imaging Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
- 8.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
- 8.1.1. By Country
- 8.1.2. By Product Type
- 8.1.3. By Application
- 8.1.4. By End-user
- 8.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
- 8.2.1. Germany
- 8.2.2. France
- 8.2.3. U.K.
- 8.2.4. Italy
- 8.2.5. Spain
- 8.2.6. Russia
- 8.3. Europe Preclinical Imaging Market Outlook: Product Type
- 8.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
- 8.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
- 8.3.2.1. Imaging Systems
- 8.3.2.1.1. Optical Imaging Systems
- 8.3.2.1.2. Nuclear Imaging Systems
- 8.3.2.1.3. Micro MRI Systems
- 8.3.2.1.4. Micro Ultrasound Systems
- 8.3.2.1.5. Micro CT Systems
- 8.3.2.1.6. Photoacoustic Imaging Systems
- 8.3.2.1.7. Magnetic Particle Imaging Systems
- 8.3.2.2. Reagents
- 8.3.2.2.1. Preclinical Optical Imaging Reagents
- 8.3.2.2.2. Preclinical Nuclear Imaging Reagents
- 8.3.2.2.3. Preclinical MRI Contrast Agents
- 8.3.2.2.4. Preclinical CT Contrast Agents
- 8.3.2.2.5. Software
- 8.3.2.1. Imaging Systems
- 8.4. Europe Preclinical Imaging Market Outlook: Application
- 8.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
- 8.4.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
- 8.4.2.1. Research and Development
- 8.4.2.2. Drug Discovery
- 8.5. Europe Preclinical Imaging Market Outlook: End-user
- 8.5.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
- 8.5.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
- 8.5.2.1. Pharmaceutical & Biotechnology Companies
- 8.5.2.2. Academic and research centres
- 8.5.2.3. Imaging Centres
- 8.5.2.4. Other End-users
- 8.6. Market Attractiveness Analysis
9. East Asia Preclinical Imaging Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
- 9.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
- 9.1.1. By Country
- 9.1.2. By Product Type
- 9.1.3. By Application
- 9.1.4. By End-user
- 9.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
- 9.2.1. China
- 9.2.2. Japan
- 9.2.3. South Korea
- 9.3. East Asia Preclinical Imaging Market Outlook: Product Type
- 9.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
- 9.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
- 9.3.2.1. Imaging Systems
- 9.3.2.1.1. Optical Imaging Systems
- 9.3.2.1.2. Nuclear Imaging Systems
- 9.3.2.1.3. Micro MRI Systems
- 9.3.2.1.4. Micro Ultrasound Systems
- 9.3.2.1.5. Micro CT Systems
- 9.3.2.1.6. Photoacoustic Imaging Systems
- 9.3.2.1.7. Magnetic Particle Imaging Systems
- 9.3.2.2. Reagents
- 9.3.2.2.1. Preclinical Optical Imaging Reagents
- 9.3.2.2.2. Preclinical Nuclear Imaging Reagents
- 9.3.2.2.3. Preclinical MRI Contrast Agents
- 9.3.2.2.4. Preclinical CT Contrast Agents
- 9.3.2.2.5. Software
- 9.3.2.1. Imaging Systems
- 9.3.3. Market Attractiveness Analysis: Product Type
- 9.4. East Asia Preclinical Imaging Market Outlook: Application
- 9.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
- 9.4.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
- 9.4.2.1. Research and Development
- 9.4.2.2. Drug Discovery
- 9.4.3. Market Attractiveness Analysis
- 9.5. East Asia Preclinical Imaging Market Outlook: End-user
- 9.5.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
- 9.5.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
- 9.5.2.1. Pharmaceutical & Biotechnology Companies
- 9.5.2.2. Academic and research centres
- 9.5.2.3. Imaging Centres
- 9.5.2.4. Other End-users
- 9.5.3. Market Attractiveness Analysis: End-user
- 9.6. Market Attractiveness Analysis
10. South Asia & Oceania Preclinical Imaging Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
- 10.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
- 10.1.1. By Country
- 10.1.2. By Product Type
- 10.1.3. By Source
- 10.1.4. By Category
- 10.1.5. By Distribution Channel
- 10.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
- 10.2.1. India
- 10.2.2. Southeast Asia
- 10.2.3. ANZ
- 10.2.4. Rest of South Asia & Oceania
- 10.3. South Asia & Oceania Preclinical Imaging Market Outlook: Product Type
- 10.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
- 10.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
- 10.3.2.1. Imaging Systems
- 10.3.2.1.1. Optical Imaging Systems
- 10.3.2.1.2. Nuclear Imaging Systems
- 10.3.2.1.3. Micro MRI Systems
- 10.3.2.1.4. Micro Ultrasound Systems
- 10.3.2.1.5. Micro CT Systems
- 10.3.2.1.6. Photoacoustic Imaging Systems
- 10.3.2.1.7. Magnetic Particle Imaging Systems
- 10.3.2.2. Reagents
- 10.3.2.2.1. Preclinical Optical Imaging Reagents
- 10.3.2.2.2. Preclinical Nuclear Imaging Reagents
- 10.3.2.2.3. Preclinical MRI Contrast Agents
- 10.3.2.2.4. Preclinical CT Contrast Agents
- 10.3.2.2.5. Software
- 10.3.2.1. Imaging Systems
- 10.4. South Asia & Oceania Preclinical Imaging Market Outlook: Application
- 10.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
- 10.4.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
- 10.4.2.1. Research and Development
- 10.4.2.2. Drug Discovery
- 10.5. South Asia & Oceania Preclinical Imaging Market Outlook: End-user
- 10.5.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
- 10.5.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
- 10.5.2.1. Pharmaceutical & Biotechnology Companies
- 10.5.2.2. Academic and research centres
- 10.5.2.3. Imaging Centres
- 10.5.2.4. Other End-users
- 10.6. Market Attractiveness Analysis
11. Latin America Preclinical Imaging Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
- 11.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
- 11.1.1. By Country
- 11.1.2. By Product Type
- 11.1.3. By Application
- 11.1.4. By End-user
- 11.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
- 11.2.1. Brazil
- 11.2.2. Mexico
- 11.3. Latin America Preclinical Imaging Market Outlook: Product Type
- 11.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
- 11.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
- 11.3.2.1. Imaging Systems
- 11.3.2.1.1. Optical Imaging Systems
- 11.3.2.1.2. Nuclear Imaging Systems
- 11.3.2.1.3. Micro MRI Systems
- 11.3.2.1.4. Micro Ultrasound Systems
- 11.3.2.1.5. Micro CT Systems
- 11.3.2.1.6. Photoacoustic Imaging Systems
- 11.3.2.1.7. Magnetic Particle Imaging Systems
- 11.3.2.2. Reagents
- 11.3.2.2.1. Preclinical Optical Imaging Reagents
- 11.3.2.2.2. Preclinical Nuclear Imaging Reagents
- 11.3.2.2.3. Preclinical MRI Contrast Agents
- 11.3.2.2.4. Preclinical CT Contrast Agents
- 11.3.2.2.5. Software
- 11.3.2.1. Imaging Systems
- 11.4. Latin America Preclinical Imaging Market Outlook: Application
- 11.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
- 11.4.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
- 11.4.2.1. Research and Development
- 11.4.2.2. Drug Discovery
- 11.5. Latin America Preclinical Imaging Market Outlook: End-user
- 11.5.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
- 11.5.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
- 11.5.2.1. Pharmaceutical & Biotechnology Companies
- 11.5.2.2. Academic and research centres
- 11.5.2.3. Imaging Centres
- 11.5.2.4. Other End-users
- 11.6. Market Attractiveness Analysis
12. Middle East & Africa Preclinical Imaging Outlook: Historical (2019-2023) and Forecast (2024-2031)
- 12.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
- 12.1.1. By Country
- 12.1.2. By Product Type
- 12.1.3. By Application
- 12.1.4. By End-user
- 12.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
- 12.2.1. GCC
- 12.2.2. South Africa
- 12.2.3. Northern Africa
- 12.3. Middle East & Africa Preclinical Imaging Market Outlook: Product Type
- 12.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
- 12.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
- 12.3.2.1. Imaging Systems
- 12.3.2.1.1. Optical Imaging Systems
- 12.3.2.1.2. Nuclear Imaging Systems
- 12.3.2.1.3. Micro MRI Systems
- 12.3.2.1.4. Micro Ultrasound Systems
- 12.3.2.1.5. Micro CT Systems
- 12.3.2.1.6. Photoacoustic Imaging Systems
- 12.3.2.1.7. Magnetic Particle Imaging Systems
- 12.3.2.2. Reagents
- 12.3.2.2.1. Preclinical Optical Imaging Reagents
- 12.3.2.2.2. Preclinical Nuclear Imaging Reagents
- 12.3.2.2.3. Preclinical MRI Contrast Agents
- 12.3.2.2.4. Preclinical CT Contrast Agents
- 12.3.2.2.5. Software
- 12.3.2.1. Imaging Systems
- 12.4. Middle East & Africa Preclinical Imaging Market Outlook: Application
- 12.4.1. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
- 12.4.2. Current Market Size (US$ Bn) Forecast By Application, 2024-2031
- 12.4.2.1. Research and Development
- 12.4.2.2. Drug Discovery
- 12.5. Middle East & Africa Preclinical Imaging Market Outlook: End-user
- 12.5.1. Historical Market Size (US$ Bn) Analysis By End-user, 2019-2023
- 12.5.2. Current Market Size (US$ Bn) Forecast By End-user, 2024-2031
- 12.5.2.1. Pharmaceutical & Biotechnology Companies
- 12.5.2.2. Academic and research centres
- 12.5.2.3. Imaging Centres
- 12.5.2.4. Other End-users
- 12.6. Market Attractiveness Analysis
13. Competition Landscape
- 13.1. Market Share Analysis, 2024
- 13.2. Market Structure
- 13.2.1. Competition Intensity Mapping By Market
- 13.2.2. Competition Dashboard
- 13.2.3. Tier Structure Analysis
- 13.2.4. Regional Presence Analysis
- 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 13.3.1. Bruker Corporation
- 13.3.1.1. Overview
- 13.3.1.2. Segments and Products
- 13.3.1.3. Key Financials
- 13.3.1.4. Market Developments
- 13.3.1.5. Market Strategy
- 13.3.2. Siemens A.G.
- 13.3.3. General Electric (GE)
- 13.3.4. TriFoil Imaging
- 13.3.5. PerkinElmer, Inc.
- 13.3.6. VisualSonics Inc.(Fujifilm)
- 13.3.7. Mediso Ltd.
- 13.3.8. Agilent Technologies
- 13.3.9. MILabs B.V.
- 13.3.10. MR Solutions
- 13.3.11. Molecubes
- 13.3.1. Bruker Corporation
14. Appendix
- 14.1. Research Methodology
- 14.2. Research Assumptions
- 14.3. Acronyms and Abbreviations
